Donor-derived white blood cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Donor-derived white blood cells, covering 2024-12-04 to 2024-12-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study Using White Blood Cells From Healthy Donors To Treat Solid Cancers [Phase 1, Phase 2]